Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated
Crossref DOI link: https://doi.org/10.1186/s12874-016-0110-x
Published Online: 2016-02-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Royston, Patrick
Parmar, Mahesh K.B.
Funding for this research was provided by:
Medical Research Council (GB)
